Association Between Systemic Inflammation Response Index, Worsening of Left Ventricular Systolic Function and

Huangtao Ruan1,2, Xiaozhao Lu2,3, Huan Lu2,3,4

  • 1Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.

Insights

High systemic inflammation response index (SIRI) is linked to worsening left ventricular systolic function in coronary artery disease (CAD) patients. This worsening also contributes to cardiovascular and all-cause mortality in CAD.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Echocardiography

Background:

  • Inflammation is a key factor in coronary artery disease (CAD) progression and poor prognosis.
  • Worsening left ventricular (LV) systolic function significantly impacts CAD patient outcomes.
  • The direct link between inflammation and the decline of LV systolic function in CAD remains unclear.

Purpose of the Study:

  • To investigate the association between the systemic inflammation response index (SIRI) and the worsening of LV systolic function in patients with CAD.
  • To determine if worsening LV systolic function mediates the relationship between SIRI and mortality in CAD patients.

Main Methods:

  • Retrospective analysis of patients from the Cardiorenal Improvement-II study (2007-2020) with baseline and follow-up echocardiograms.
  • Stratification of patients into four groups based on SIRI quartiles.
  • Primary endpoint: a ≥10% decrease in LV ejection fraction within 12 months post-discharge.
  • Secondary endpoints: cardiovascular and all-cause mortality, analyzed using logistic regression and mediation analysis.

Main Results:

  • Out of 6307 CAD patients, 8.3% experienced worsening LV systolic function within a year.
  • Patients in the highest SIRI quartile (Q4, ≥2.61) showed a significantly higher risk of worsening LV systolic function (aOR: 1.52, P=0.003).
  • Worsening LV systolic function mediated 4.0% of the association between SIRI and cardiovascular mortality, and 2.0% with all-cause mortality.

Conclusions:

  • Elevated SIRI is a significant risk factor for the deterioration of LV systolic function in CAD patients.
  • The decline in LV systolic function associated with high SIRI contributes to increased mortality.
  • Targeting inflammation through anti-inflammatory treatments may offer a therapeutic strategy to improve outcomes for CAD patients.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...